Next Article in Journal
The Neglected Marine Fungi, Sensu stricto, and Their Isolation for Natural Products’ Discovery
Next Article in Special Issue
Development of a Mucoadhesive and In Situ Gelling Formulation Based on κ-Carrageenan for Application on Oral Mucosa and Esophagus Walls. I. A Functional In Vitro Characterization
Previous Article in Journal
Collagen Extraction Optimization from the Skin of the Small-Spotted Catshark (S. canicula) by Response Surface Methodology
Previous Article in Special Issue
Nano-in-Micro Delivery System Prepared by Co-Axial Air Flow for Oral Delivery of Conjugated Linoleic Acid
Open AccessArticle

Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery

1
Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju 61469, Korea
2
Department of Surgery, Chonnam National University Medical School, Gwangju 61469, Korea
3
Department of Dental Hygiene, College of Health Sciences, Cheongju University, Cheongju 28503, Korea
4
Department of Biomedical Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
5
Institute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this study.
Mar. Drugs 2019, 17(1), 41; https://doi.org/10.3390/md17010041
Received: 27 December 2018 / Revised: 7 January 2019 / Accepted: 7 January 2019 / Published: 10 January 2019
(This article belongs to the Special Issue Marine Biopolymers and Drug Delivery)
In this study, we prepared an injectable drug delivery depot system based on a visible light-cured glycol chitosan (GC) hydrogel containing paclitaxel (PTX)-complexed beta-cyclodextrin (β-CD) (GC/CD/PTX) for ovarian cancer (OC) therapy using a tumor-bearing mouse model. The hydrogel depot system had a 23.8 Pa of storage modulus at 100 rad/s after visible light irradiation for 10 s. In addition, GC was swollen as a function of time. However, GC had no degradation with the time change. Eventually, the swollen GC matrix affected the releases of PTX and CD/PTX. GC/PTX and GC/CD/PTX exhibited a controlled release of PTX for 7 days. In addition, GC/CD/PTX had a rapid PTX release for 7 days due to improved water solubility of PTX through CD/PTX complex. In vitro cell viability tests showed that GC/CD/PTX had a lower cell viability percentage than the free PTX solution and GC/PTX. Additionally, GC/CD/PTX resulted in a superior antitumor effect against OC. Consequently, we suggest that the GC/CD system might have clinical potential for OC therapy by improving the water solubility of PTX, as PTX is included into the cavity of β-CD. View Full-Text
Keywords: injectable drug delivery depot system; visible light-cured glycol chitosan hydrogel; beta-cyclodextrin; paclitaxel; ovarian cancer therapy injectable drug delivery depot system; visible light-cured glycol chitosan hydrogel; beta-cyclodextrin; paclitaxel; ovarian cancer therapy
Show Figures

Figure 1

MDPI and ACS Style

Hyun, H.; Park, M.H.; Jo, G.; Kim, S.Y.; Chun, H.J.; Yang, D.H. Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery. Mar. Drugs 2019, 17, 41. https://doi.org/10.3390/md17010041

AMA Style

Hyun H, Park MH, Jo G, Kim SY, Chun HJ, Yang DH. Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery. Marine Drugs. 2019; 17(1):41. https://doi.org/10.3390/md17010041

Chicago/Turabian Style

Hyun, Hoon; Park, Min H.; Jo, Gayoung; Kim, So Y.; Chun, Heung J.; Yang, Dae H. 2019. "Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery" Mar. Drugs 17, no. 1: 41. https://doi.org/10.3390/md17010041

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop